Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO

British Journal of Cancer, Published online: 07 October 2020; doi:10.1038/s41416-020-01089-9Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO

http://feeds.nature.com/~r/bjc/rss/current/~3/acmE4EF4PNY/s41416-020-01089-9

Source: British Journal of Cancer - October 6, 2020 Category: Cancer & Oncology Authors: Daniele Rossini Sara Lonardi Carlotta Antoniotti Daniele Santini Gianluca Tomasello Paola Ermacora Marco Maria Germani Francesca Bergamo Vincenzo Ricci Salvatore Caponnetto Roberto Moretto Alberto Zaniboni Filippo Pietrantonio Angela Buonadonna Giuliana R Source Type: research